NasdaqGM:LGNDPharmaceuticals
Is It Too Late To Consider Ligand Pharmaceuticals (LGND) After A 105% One-Year Surge?
If you are wondering whether Ligand Pharmaceuticals at US$221.24 is still offering value after a big run, you are not alone. That is exactly what this article will unpack.
The stock has returned 5.9% over the last 7 days, 18.4% over the last 30 days, 16.4% year to date, 104.7% over 1 year and 209.0% over 3 years, with a 5 year return of 106.6%.
Recent headlines around Ligand Pharmaceuticals have focused on its role in the pharmaceuticals and biotech space and how the market is reassessing...